INTUITIVE SURGICAL AND NEW SURGICAL ROBOT
- Intuitive Surgical, Inc. $ISRG: Shares rose significantly after promising news about a new surgical robot and beating expectations for the fourth quarter.
- The new Da Vinci 5 surgical robot: The company filed for its registration with the FDA, which Citi analysts called a highlight and hinting at the next generation of robotic surgery.
- Financial results: Earnings for the quarter came in at $1.60 per share, beating Wall Street expectations, and revenue rose to $1.93 billion.
- Growth in surgical system installations: Installations of da Vinci Surgical Systems increased 21%, leading to strong revenue growth.
- Market development: The stock has seen a 52% increase in the last year.
- MedTech industry expectations: Analyst at Truist Securities expects Intuitive Surgical to remain a leader in robotic surgery innovation.
- Future and innovation: The successful filing of a new robot application and early results indicate a bright future for the company and the MedTech industry.
How do you see the impact of Intuitive Surgical's new Da Vinci 5 surgical robot on the future of surgery and how could this technological advancement impact the company's stock and the MedTech industry?
